Point-of-Care Blood Glucose Monitoring System Measures and Corrects Hematocrit and Electrochemical Interferences
Posted December 30th, 2011.
An advanced blood glucose monitoring system from Nova Biomedical elevates bedside glucose testing to a new level of analytical performance that approaches the quality of central laboratory testing. The Nova StatStrip™ point-of-care glucose monitor incorporates a patented* new strip technology that uses four measuring wells. Current glucose strips use only one well. Nova’s Multi-Well™ system measures and corrects hematocrit interferences as well as interferences from acetaminophen (Tylenol), uric acid, ascorbic acid (Vitamin C), maltose, galactose, xylose, and lactose. StatStrip also eliminates oxygen interference to provide accurate glucose results regardless of the sample’s oxygen status.
StatStrip’s 6-second analysis time, color touch screen operation, and simple operating steps make bedside glucose testing fast and easy for point-of-care staff. Its small 1.2 microliter sample size results in easy sample acquisition and minimal pain for the patient. Unlike competitive glucose analyzers, StatStrip requires no calibration codes, thereby eliminating an operator step and preventing a potential input error.
Comprehensive instrument manager software provides management, control, and regulatory compliance, and allows the StatStrip system to be completely customized to the needs of each department within the hospital.
*Patent Number 6,287,451/6,837,976/EP/1,212,609/CA 2,375,092